Emory University
Pediatric Hematology-Oncology fellowship · Atlanta, GA · Program website
Pediatrics residency here · Other fellowships: Neonatal-Perinatal Medicine · Pediatric Cardiology · Pediatric Critical Care Medicine · Pediatric Emergency Medicine · Pediatric Gastroenterology · Pediatric Infectious Diseases · Pediatric Pulmonology · Pediatric Endocrinology · Pediatric Nephrology
Roster not collected yet. There's no list of this program's own faculty, trainees, or papers yet. Below is Emory University's research in pediatric hematology-oncology, which the program shares with other departments and affiliated hospitals.
Pediatric Hematology-Oncology at Emory Universityshared by every program there, not this program's own
Institution-level: all pediatric hematology-oncology publications from Emory University and affiliated institutions, since 2022. Updated 2026-11-07; refreshed daily.
Works per year · * 2026 so far
Pediatric Hematology-Oncology research topics at Emory University
Papers in the window; each links to the list on OpenAlex.
- Multiple Myeloma Research and Treatments 272
- Cancer Immunotherapy and Biomarkers 244
- Glioma Diagnosis and Treatment 214
- Hematopoietic Stem Cell Transplantation 192
- Acute Myeloid Leukemia Research 153
- CAR-T cell therapy research 153
- Renal cell carcinoma treatment 150
- Pancreatic and Hepatic Oncology Research 132
Most cited at Emory University since 2024
All pediatric hematology-oncology papers there on OpenAlex
- The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Lisa M Force et al. · The Lancet · 2025 · PubMed · cited 498
- Management of Fatigue in Adult Survivors of Cancer: ASCO–Society for Integrative Oncology Guideline UpdateJulienne E. Bower et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 317
- Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast CancerNicholas C. Turner et al. · New England Journal of Medicine · 2024 · PubMed · cited 313
- Menin Inhibition With Revumenib for KMT2A -Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)Ghayas C. Issa et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 262
- Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in ChildrenSumit Gupta et al. · New England Journal of Medicine · 2024 · PubMed · cited 240
- Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3Mark J. Levis et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 233
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2018–2022Mackenzie Price et al. · Neuro-Oncology · 2025 · PubMed · cited 227
- Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: Primary Results From TROPION-Breast01Aditya Bardia et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 224
- First-Line Camizestrant for Emerging ESR1 -Mutated Advanced Breast CancerFrançois‐Clément Bidard et al. · New England Journal of Medicine · 2025 · PubMed · cited 212
- International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple MyelomaHervé Avet‐Loiseau et al. · Journal of Clinical Oncology · 2025 · PubMed · cited 206
Add to your program's websitea badge, your paper list, a feed
For program directors and coordinators. Both update with the site and need no account.
<a href="https://openprograms.org/programs/emory-university-peds-heme-onc"><img src="https://openprograms.org/programs/emory-university-peds-heme-onc/badge.svg" alt="Emory University Pediatric Hematology-Oncology fellowship on OpenPrograms" height="20"></a>Something wrong or missing on this page? Use the correction form below; changes show up in both.